Showing 471-480 of 2166 results for "".
Much Ado About the Ocular Surface
https://modernod.com/topics/ocular-surface/much-ado-about-the-ocular-surface/38762/Best Online Moments of 2019
https://modernod.com/topics/business/best-online-moments-of-2019/38019/A look back at some of Modern Optometry’s favorite social media posts and online offerings from the past year.A Problem and a Promising Solution
https://modernod.com/articles/visually-induced-dysphoria-a-potential-leading-source-of-headaches-eyestrain-and-dry-eye-sensation/a-problem-and-a-promising-solution/37973/Neurology and optometry come together to investigate relief for patients with dry eye symptoms and chronic headache.A Student’s Perspective on the
Changing Landscape of Optometryhttps://modernod.com/topics/human-interest/a-students-perspective-on-the-changing-landscape-of-optometry/38604/Drawing from experience, the author reflects on how unconventional paths can affect the lives, perspectives, and opportunities of today’s students.The Neuro-Optometric Rehabilitation Association
https://modernod.com/topics/neuro-optometry/the-neuro-optometric-rehabilitation-association/38215/Enhancing neurologic recovery through vision rehabilitation.Optometric Cornea, Cataract and Refractive Society
https://modernod.com/mod-issues/2021-oct/optometric-cornea-cataract-and-refractive-society/38306/A forum for clinicians, researchers, and business owners to connect over all things refractive.Inside the Innovator’s Mind
https://modernod.com/mod-issues/2022-mar/inside-the-innovators-mind/38391/What does it take to be a game-changer in optometry? Hear from four innovators who’ve run the gamut.Pterygium
https://modernod.com/topics/business/pterygium/38132/Intrepid Eye Society
https://modernod.com/mod-issues/2021-july-aug/intrepid-eye-society/38256/Working to empower the next generation.Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
https://modernod.com/cme/ophthalmology/eye-on-the-target-2421/33187/Specialists in eye care and oncology come together to discuss strategies to manage ocular toxicities associated with specific cancer drugs.